The Targeted Surveillance of Newly-defined Ventilator-associated Pneumonia_West China Medical Journal

Authors：

 ZhuShichao ¹ , ZongZhiyong ^1,2 , QiaoFu ¹ , ZhangHui ¹ , LiJingwen ¹ , CaiLin ³ , YinWeijia ¹

1. Department of Nosocomial Infection Management;West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
2. Center of Infectious Diseases;West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
3. Intensive Care Unit;West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

YinWeijia, Email:

Keywords：

Nosocomial infection; Intensive care unit; Targeted surveillance; Ventilator-associated pneumonia; Prognosis

DOI：

10.7507/1002-0179.201600114

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To carry out targeted surveillance on ventilator-associated pneumonia (VAP) newly defined by the Centers for Disease Control and Prevention of the United States in 2013, and to understand its applicability and influence on the prognosis, and infection rate and risk factors of the disease. Methods Targeted surveillance was carried out on all patients receiving mechanical ventilation in the general ICU of our hospital between January and December 2014. VAP infection rate was studied, and patients were divided into groups based on the development of the disease. SPSS 18.0 was used for statistical analysis of the prognostic indicators. Results A total of 885 patients received mechanical ventilation and were monitored, 31 of whom had VAP. The VAP case infection rate was 3.5% and its daily infection rate was 3.9‰. The results of multiple factors regression analysis showed that age (OR=1.025, P=0.025) and combining other types of hospital infection (OR=4.874, P<0.001) were independent risk factors for the development of VAP. VAP was the independent risk factor for both length of stay in the ICU and length of mechanical ventilation (P<0.001), but it was not the independent risk factor for mortality in the ICU (P=0.515). Conclusion The applicability of the newly defined ventilator-associated pneumonia may be under restrictions in developing countries. It may influence the outcomes of patients by prolonging the length of stay in ICU and the length of mechanical ventilation.

Citation： ZhuShichao, ZongZhiyong, QiaoFu, ZhangHui, LiJingwen, CaiLin, YinWeijia. The Targeted Surveillance of Newly-defined Ventilator-associated Pneumonia. West China Medical Journal, 2016, 31(3): 418-421. doi: 10.7507/1002-0179.201600114 Copy

1.	王醒, 程璐, 陈明祺, 等. 呼吸机相关性肺炎防治进展[J]. 现代医学, 2013, 41(8):581-584.
2.	李蓓, 黎檀实. 呼吸机相关肺炎诊断标准的探讨[J]. 临床急诊杂志, 2014, 15(5):306-308.
3.	吕宇, 刘华, 王慧, 等. 神经外科重症监护病房医院感染目标性监测分析[J]. 华西医学, 2014, 29(10):1908-1911.
4.	毛彦华, 刘锦铭. 呼吸机相关性肺炎危险因素研究[J]. 中华医院感染学杂志, 2011, 21(12):2438-2440.
5.	向丽佳, 宋晓英, 郑晓红, 等. 综合重症监护病房医院感染目标性监测分析[J]. 华西医学, 2014, 29(3):432-435.
6.	Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2011, device-associated module[J]. Am J Infect Control, 2013, 41(4):286-300.
7.	Ashraf M, Ostrosky-Zeichner L. Ventilator-associated pneumonia:a review[J]. Hosp Pract (1995), 2012, 40(1):93-105.
8.	Joseph NM, Sistla S, Dutta TK, et al. Ventilator-associated pneumonia:a review[J]. Eur J Intern Med, 2010, 21(5):360-368.
9.	National Healthcare Safety Network. Ventilator-associated pneumonia (VAP) event[EB/OL]. CDC/NHSN Protocol Clarifications, (2013-07)[2016-01]. http://www.cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf.
10.	余威英, 徐小娟, 魏凌云, 等. 呼吸机相关性肺炎感染的危险因素分析[J]. 中华医院感染学杂志, 2014, 24(1):112-113, 127.
11.	陈仁辉, 陶福正, 陈英姿, 等. 呼吸机相关性肺炎的危险因素与病原菌分析[J]. 中华医院感染学杂志, 2014, 24(24):6042-6044.
12.	管军, 杨兴易, 赵良. 综合性ICU中呼吸机相关性肺炎危险因素多元逐步Logistic回归分析[J]. 第二军医大学学报, 2003, 24(7):780-783.
13.	童忠满. 呼吸机相关肺炎早期诊断及预后相关研究进展[J]. 医学综述, 2012, 18(1):82-85.
14.	娄伟, 魏碧蓉, 谢伟芬. 呼吸机相关性肺炎影响因素的logistic回归分析及预防[J]. 赣南医学院学报, 2014, 34(1):47-50.
15.	黄红铃, 陈永元, 肖莎. 呼吸机相关性肺炎发生率及危险因素分析[J]. 中华医院感染学杂志, 2014, 24(17):4240-4242.
16.	贾随明. 呼吸机相关性肺炎的危险因素分析及防控[J]. 医学理论与实践, 2015, 28(2):149-150.
17.	和瑞莲, 张国际. 呼吸机相关性肺炎的危险因素及病原学分析[J]. 中国社区医师, 2014, 30(10):26, 28.

1. 王醒, 程璐, 陈明祺, 等. 呼吸机相关性肺炎防治进展[J]. 现代医学, 2013, 41(8):581-584.
2. 李蓓, 黎檀实. 呼吸机相关肺炎诊断标准的探讨[J]. 临床急诊杂志, 2014, 15(5):306-308.
3. 吕宇, 刘华, 王慧, 等. 神经外科重症监护病房医院感染目标性监测分析[J]. 华西医学, 2014, 29(10):1908-1911.
4. 毛彦华, 刘锦铭. 呼吸机相关性肺炎危险因素研究[J]. 中华医院感染学杂志, 2011, 21(12):2438-2440.
5. 向丽佳, 宋晓英, 郑晓红, 等. 综合重症监护病房医院感染目标性监测分析[J]. 华西医学, 2014, 29(3):432-435.
6. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) report, data summary for 2011, device-associated module[J]. Am J Infect Control, 2013, 41(4):286-300.
7. Ashraf M, Ostrosky-Zeichner L. Ventilator-associated pneumonia:a review[J]. Hosp Pract (1995), 2012, 40(1):93-105.
8. Joseph NM, Sistla S, Dutta TK, et al. Ventilator-associated pneumonia:a review[J]. Eur J Intern Med, 2010, 21(5):360-368.
9. National Healthcare Safety Network. Ventilator-associated pneumonia (VAP) event[EB/OL]. CDC/NHSN Protocol Clarifications, (2013-07)[2016-01]. http://www.cdc.gov/nhsn/PDFs/pscManual/6pscVAPcurrent.pdf.
10. 余威英, 徐小娟, 魏凌云, 等. 呼吸机相关性肺炎感染的危险因素分析[J]. 中华医院感染学杂志, 2014, 24(1):112-113, 127.
11. 陈仁辉, 陶福正, 陈英姿, 等. 呼吸机相关性肺炎的危险因素与病原菌分析[J]. 中华医院感染学杂志, 2014, 24(24):6042-6044.
12. 管军, 杨兴易, 赵良. 综合性ICU中呼吸机相关性肺炎危险因素多元逐步Logistic回归分析[J]. 第二军医大学学报, 2003, 24(7):780-783.
13. 童忠满. 呼吸机相关肺炎早期诊断及预后相关研究进展[J]. 医学综述, 2012, 18(1):82-85.
14. 娄伟, 魏碧蓉, 谢伟芬. 呼吸机相关性肺炎影响因素的logistic回归分析及预防[J]. 赣南医学院学报, 2014, 34(1):47-50.
15. 黄红铃, 陈永元, 肖莎. 呼吸机相关性肺炎发生率及危险因素分析[J]. 中华医院感染学杂志, 2014, 24(17):4240-4242.
16. 贾随明. 呼吸机相关性肺炎的危险因素分析及防控[J]. 医学理论与实践, 2015, 28(2):149-150.
17. 和瑞莲, 张国际. 呼吸机相关性肺炎的危险因素及病原学分析[J]. 中国社区医师, 2014, 30(10):26, 28.

West China Medical Journal

The Targeted Surveillance of Newly-defined Ventilator-associated Pneumonia

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content